LAS VEGAS, Nov. 24, 2014 /PRNewswire/ -- RAMOIL MANAGEMENT,
Ltd (OTCPink: RAMO) announces that RAMO Bio-Med, Inc., its wholly
owned subsidiary, has a new Facebook page showing pictures of its
CBD Clones, scheduled for mid-January, 2015 harvest, to be used in
Q1-2015 "RAMO CBD Pain" and "RAMO CBD Sleep" product
production.
www.facebook.com/ramobiomed
Michael Goeree, Ramoil
Management's Chairman, President and Chief Executive Officer,
said: "Per our November 18,
2014 press release "RAMO Bio-Med, Inc. is presently ramping
up production", we believe that pictures are far better than words
and our present and future shareholders would appreciate the visual
update in progress, as well."
Mr. Goeree further stated: "On this Facebook page, I will be
periodically posting comments and answering questions, so please
stay involved."
About Ramoil Management, Ltd.
Ramoil Management, Ltd.
(RAMO) is a development stage company. The Company is an
online wholesaler of E-cigarettes containing nutraceutical vapor
oils, E-cigarette delivery systems and hydroponic lighting and
nutrients. Through its wholly owned subsidiary, RAMO Bio-Med,
Inc., it is operating a "Supercritical CO2 Molecular Extraction"
system and is planning to build production facilities and research
labs, both domestically and internationally, focused on its own
proprietary strain of high CBD – extremely low THC Extraction
Facilities (Labs and Manufacturing), for the development,
production and sales of CBD extractions, concentrates and
medicines.
Forward Looking Statements:
This news release contains forward-looking statements made by
RAMOIL MANAGEMENT, LTD. All such statements included in this press
release, other than statements of historical fact, are
forward-looking statements. Although management believes that
the expectations reflected in such forward-looking statements are
reasonable, it can give no assurance that such expectations will
prove to have been correct. Actual results may differ materially
from those indicated by these statements. The following risk
factors, among others, could cause actual results to differ
materially from those described in any forward-looking statements.
These risks and uncertainties include, but are not limited to,
economic conditions, changes in the law or regulations, demand for
products of the Company, the effects of competition and other
factors that could cause actual results to differ materially from
those projected or represented in the forward looking statements.
Forward-looking statements are typically identified by the words:
believe, expect, anticipate, intend, estimate, and similar
expressions or which by their nature refer to future events.
The Company is not entitled to rely on the safe harbor provisions
of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934 because it is not registered under
either Act.
Company and Investor Relations Contact:
Frank Blainey, Esq. at:
+1-702-381-1961
Ramoilir@gmail.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ramoil-management-ltd-announces-ramo-bio-med-facebook-page--cbd-clone-production-photos-300000138.html
SOURCE Ramoil Management, Ltd.